Your browser doesn't support javascript.
loading
SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing.
Kist, Andreas M; Sagafos, Dagrun; Rush, Anthony M; Neacsu, Cristian; Eberhardt, Esther; Schmidt, Roland; Lunden, Lars Kristian; Ørstavik, Kristin; Kaluza, Luisa; Meents, Jannis; Zhang, Zhiping; Carr, Thomas Hedley; Salter, Hugh; Malinowsky, David; Wollberg, Patrik; Krupp, Johannes; Kleggetveit, Inge Petter; Schmelz, Martin; Jørum, Ellen; Lampert, Angelika; Namer, Barbara.
Afiliación
  • Kist AM; Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Sagafos D; Section of Clinical Neurophysiology, Department of Neurology, Oslo University Hospital -Rikshospitalet, Oslo, Norway.
  • Rush AM; AstraZeneca R&D, Södertälje, Sweden.
  • Neacsu C; Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Eberhardt E; Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Schmidt R; Department of Anesthesiology, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
  • Lunden LK; Department of Neuroscience, Clinical Neurophysiology, Uppsala University, Uppsala, Sweden.
  • Ørstavik K; Section of Clinical Neurophysiology, Department of Neurology, Oslo University Hospital -Rikshospitalet, Oslo, Norway.
  • Kaluza L; Section of Clinical Neurophysiology, Department of Neurology, Oslo University Hospital -Rikshospitalet, Oslo, Norway.
  • Meents J; Institute of Physiology, RWTH Aachen University Hospital, Aachen, Germany.
  • Zhang Z; Institute of Physiology, RWTH Aachen University Hospital, Aachen, Germany.
  • Carr TH; AstraZeneca R&D, Södertälje, Sweden.
  • Salter H; AstraZeneca R&D, Cambridge, United Kingdom.
  • Malinowsky D; AstraZeneca R&D, Södertälje, Sweden.
  • Wollberg P; AstraZeneca R&D, Södertälje, Sweden.
  • Krupp J; AstraZeneca R&D, Södertälje, Sweden.
  • Kleggetveit IP; AstraZeneca R&D, Södertälje, Sweden.
  • Schmelz M; Section of Clinical Neurophysiology, Department of Neurology, Oslo University Hospital -Rikshospitalet, Oslo, Norway.
  • Jørum E; Department of Anesthesiology Mannheim, Heidelberg University, Mannheim, Germany.
  • Lampert A; Section of Clinical Neurophysiology, Department of Neurology, Oslo University Hospital -Rikshospitalet, Oslo, Norway.
  • Namer B; Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
PLoS One ; 11(9): e0161789, 2016.
Article en En | MEDLINE | ID: mdl-27598514
ABSTRACT
Gain-of-function mutations in the tetrodotoxin (TTX) sensitive voltage-gated sodium channel (Nav) Nav1.7 have been identified as a key mechanism underlying chronic pain in inherited erythromelalgia. Mutations in TTX resistant channels, such as Nav1.8 or Nav1.9, were recently connected with inherited chronic pain syndromes. Here, we investigated the effects of the p.M650K mutation in Nav1.8 in a 53 year old patient with erythromelalgia by microneurography and patch-clamp techniques. Recordings of the patient's peripheral nerve fibers showed increased activity dependent slowing (ADS) in CMi and less spontaneous firing compared to a control group of erythromelalgia patients without Nav mutations. To evaluate the impact of the p.M650K mutation on neuronal firing and channel gating, we performed current and voltage-clamp recordings on transfected sensory neurons (DRGs) and neuroblastoma cells. The p.M650K mutation shifted steady-state fast inactivation of Nav1.8 to more hyperpolarized potentials and did not significantly alter any other tested gating behaviors. The AP half-width was significantly broader and the stimulated action potential firing rate was reduced for M650K transfected DRGs compared to WT. We discuss the potential link between enhanced steady state fast inactivation, broader action potential width and the potential physiological consequences.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dolor / Eritromelalgia / Canal de Sodio Activado por Voltaje NAV1.8 / Ganglios Espinales Tipo de estudio: Prognostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dolor / Eritromelalgia / Canal de Sodio Activado por Voltaje NAV1.8 / Ganglios Espinales Tipo de estudio: Prognostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Alemania